PHAXIAM Therapeutics SA (DELISTED) (PHXM:DL)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
PHAXIAM Therapeutics Price to Book Value: 0.4731 for March 11, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 11, 2024 | 0.4731 |
| March 08, 2024 | 0.4731 |
| March 07, 2024 | 0.4761 |
| March 06, 2024 | 0.4593 |
| March 05, 2024 | 0.4593 |
| March 04, 2024 | 0.3815 |
| March 01, 2024 | 0.4288 |
| February 29, 2024 | 0.4181 |
| February 28, 2024 | 0.4181 |
| February 27, 2024 | 0.4562 |
| February 26, 2024 | 0.4562 |
| February 23, 2024 | 0.4433 |
| February 22, 2024 | 0.4319 |
| February 21, 2024 | 0.4319 |
| February 20, 2024 | 0.5783 |
| February 16, 2024 | 0.5646 |
| February 15, 2024 | 0.5646 |
| February 14, 2024 | 0.5722 |
| February 13, 2024 | 0.5722 |
| February 12, 2024 | 0.5722 |
| February 09, 2024 | 0.6089 |
| February 08, 2024 | 0.6089 |
| February 07, 2024 | 0.6089 |
| February 06, 2024 | 0.6135 |
| February 05, 2024 | 0.6135 |
| Date | Value |
|---|---|
| February 02, 2024 | 0.6142 |
| February 01, 2024 | 0.6409 |
| January 31, 2024 | 0.6424 |
| January 30, 2024 | 0.6409 |
| January 29, 2024 | 0.6714 |
| January 26, 2024 | 0.705 |
| January 25, 2024 | 0.676 |
| January 24, 2024 | 0.7172 |
| January 23, 2024 | 0.7248 |
| January 22, 2024 | 0.7828 |
| January 19, 2024 | 0.7172 |
| January 18, 2024 | 0.7172 |
| January 17, 2024 | 0.792 |
| January 16, 2024 | 0.792 |
| January 12, 2024 | 0.7325 |
| January 11, 2024 | 0.7137 |
| January 10, 2024 | 0.7137 |
| January 09, 2024 | 0.702 |
| January 08, 2024 | 0.8103 |
| January 05, 2024 | 0.7767 |
| January 04, 2024 | 0.7798 |
| January 03, 2024 | 0.795 |
| January 02, 2024 | 0.7325 |
| December 29, 2023 | 0.6775 |
| December 28, 2023 | 0.7142 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3815
Minimum
Mar 04 2024
7.38
Maximum
Jan 19 2021
1.839
Average
1.320
Median
Jan 07 2020
Price to Book Value Benchmarks
| DBV Technologies SA | 0.7850 |
| Cellectis SA | 2.787 |
| Genfit SA | 2.456 |
| Innate Pharma SA | 3.706 |
| Inventiva SA | -- |
Price to Book Value Related Metrics
| PE Ratio | 1.031 |
| Price | 3.10 |
| Earnings Yield | 96.99% |